AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas.

about

The Gas6/TAM System and Multiple Sclerosis Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models.

P2860

Q28067131-987E9F94-DE5F-44D9-9C5D-769EB6F1DDD8 Q47141265-2204EB56-6118-4953-8390-4B1EB9E873B7

P2860

AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas.

Item

http://www.wikidata.org/entity/Q35843071

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas.

@ast

AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas.

@en

type

Item

label

AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas.

@ast

AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas.

@en

prefLabel

AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas.

@ast

AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas.

@en

P1476

AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas.

@en

P2093

Azad Abul Kalam

http://www.w3.org/2001/XMLSchema#string

Caitlin D May

http://www.w3.org/2001/XMLSchema#string

Christine M Kivlin

http://www.w3.org/2001/XMLSchema#string

Davis R Ingram

http://www.w3.org/2001/XMLSchema#string

Dina Lev

http://www.w3.org/2001/XMLSchema#string

Dominique Broccoli

http://www.w3.org/2001/XMLSchema#string

Elizabeth G Demicco

http://www.w3.org/2001/XMLSchema#string

Fuguo Zhou

http://www.w3.org/2001/XMLSchema#string

Ghadah A Al Sannaa

http://www.w3.org/2001/XMLSchema#string

Jeannine Garnett

http://www.w3.org/2001/XMLSchema#string

P2860

NIH Image to ImageJ: 25 years of image analysis

axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase

AXL kinase as a novel target for cancer therapy

Cancer statistics, 2012

Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma

A novel putative tyrosine kinase receptor with oncogenic potential

Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival.

Doxorubicin resistance in a novel in vitro model of human pleomorphic liposarcoma associated with alternative lengthening of telomeres.

Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma.

Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET.

P2888

s12885-015-1916-3

P304

901

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-015-1916-3

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alexander J. Lazar

P577

2015-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283860231

http://www.w3.org/2001/XMLSchema#string

P6179

1036318004

http://www.w3.org/2001/XMLSchema#string

P698

26573603

http://www.w3.org/2001/XMLSchema#string

P932

4647521

http://www.w3.org/2001/XMLSchema#string

AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas.

about

P2860

P2860

AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P5875

P6179

P698

P932